A cost-effectiveness analysis of smoking cessation interventions in the UK accounting for major neuropsychiatric adverse events

Edna Keeney*, Nicky J Welton, Matt Stevenson, Michael N Dalili, José A López-López, Deborah M Caldwell, David M Phillippo, Marcus R Munafò, Kyla H Thomas

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

5 Citations (Scopus)
63 Downloads (Pure)

Fingerprint

Dive into the research topics of 'A cost-effectiveness analysis of smoking cessation interventions in the UK accounting for major neuropsychiatric adverse events'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science